Venture capital firm Kineticos Life Sciences has launched a new biotech to take forward a class of antibiotics forged in the labs of Harvard University. Kineticos has already set up an accelerator ...

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

Basilea secured the license option for the endolysin antibiotic, called tonabacase, from Korea’s iNtRON Biotechnology in 2023. Basilea had been conducting a preclinical evaluation of the asset ...

Mar. 4, 2025 — A vivid new image is taking shape in the world of cell biology: Imagine bacteria adhering to the surface of a cell, perhaps at the site of an injury or wound. In response, a white ...

Antibiotics can cause side effects, such as abdominal pain and loss of appetite. Eating certain foods may help prevent these types of side effects. Antibiotics are medications that fight bacteria ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The scientific community is reeling in the wake of the Trump ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

CrisprBits, a Bengaluru-based biotech startup, has developed a platform from CRISPR-based molecular diagnostics for early detection of antibiotic resistance in hospital-acquired infections.